COP LEY 114
Pill imprint COP LEY 114 has been identified as Procainamide hydrochloride SR 750 mg.
Procainamide is used in the treatment of arrhythmia and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy.
Procainamide 750 mg is not subject to the Controlled Substances Act.
See also related documents.
Procainamide hydrochloride SR Images
- Imprint:
-
COP LEY
114 - Strength:
- 750 mg
- Color:
- Orange
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Group I antiarrhythmics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
More Procainamide Hydrochloride SR resources
- Procainamide (Wolters Kluwer)
- Procainamide Capsules (Wolters Kluwer)
- Procainamide Controlled-Release (Wolters Kluwer)
- procainamide injection (Cerner Multum)
- procainamide Intravenous (Micromedex) - Includes Dosage Information
- Procainamide Hydrochloride (AHFS DI)
- Procainamide (FDA)
- Procainamide capsules (FDA)
- Procainamide Hydrochloride (Wolters Kluwer)


